Hematology
Shaalan Beg, MD
Vice President of Oncology, Science 37; Adjunct Associate Professor, Hematology and Oncology, University of Texas Southwestern Medical Center; Chief Medical Officer, Oncology, ConcertAI
Dr. Shaalan Beg, MD, MS, is a medical oncologist specializing in the diagnosis and treatment of all types of cancer and benign and malignant tumors, with particular expertise in gastrointestinal cancers including pancreatic cancer and biliary tract cancer. He serves as Vice President of Oncology at Science 37, focusing on decentralized clinical trials, health information technology, and equity in access to care. Previously affiliated with University of Texas Southwestern Medical Center, he holds
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- UT Southwestern — MS, Clinical Science, 2012-2015
- University of Cincinnati Medical Center/College of Medicine — Fellowship, Hematology and Medical Oncology, 2008-2011
- University of Cincinnati Medical Center/College of Medicine — Residency, Internal Medicine, 2005-2008
- Aga Khan Medical College — MD, 2003
Peer Recognition
- American Society of Clinical Oncology — Fellow
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- UT Southwestern Medical Center
- Saint Alphonsus Regional Medical Center
- Texoma Medical Center
- Baylor Scott and White Medical Center-Waxahachie
- Parkland Health & Hospital System
Languages
English